6533b86ffe1ef96bd12cd41a

RESEARCH PRODUCT

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases.

Maria CappelloB. ScrivoGiuseppe Ingrassia StranoNicasio VenturaMaria VadalàSalvatore CillinoCalogero CammàMassimo CastellucciChiara DavìE. Giuffrida

subject

Clinical teammedicine.medical_specialtygenetic structuresScreening testPilot ProjectsInflammatory bowel diseaseBiological drugsQuality of lifeInternal medicineSurveys and QuestionnairesmedicineHumansBlindnessBiologic drugs Inflammatory bowel disease Ocular extraintestinal manifestation QuestionnaireOphthalmologistsbusiness.industrySettore MED/30 - Malattie Apparato VisivoInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel Diseasesdigestive system diseaseseye diseasesOphthalmologyOphthalmologic examinationQuality of Lifebusiness

description

Purpose: To assess the usefulness of a dedicated questionnaire for patients with inflammatory bowel diseases (IBD) treated with biological drugs for the detection of ocular extraintestinal manifestations (EIMs). IBD can cause extraintestinal symptoms including ocular complaints which are frequently ignored and may be associated with significant morbidity, including blindness. Methods: We developed a questionnaire, named Ocular Manifestations in IBD Screening (OMIS) questionnaire, after agreement between gastroenterologists and ophthalmologists. The questionnaire was administered by a non-ophthalmologist physician to 96 IBD patients treated with biological drugs. Results: 35 patients (36.5%) were selected for the ophthalmologic examination on the basis of a positive screening test. Ocular EIMs were detected in 29 of 35 patients (83%). Conclusion: A specific questionnaire can be useful for non-ophthalmologist physicians in a real world setting in order to select patients to be addressed to an ophthalmological visit, creating an integrated multidisciplinary clinical team, to improve management of IBD in order to prevent disability and guarantee quality of life.

yearjournalcountryeditionlanguage
2020-02-23International ophthalmology
10.1155/2018/8618703https://pubmed.ncbi.nlm.nih.gov/32507951